Convelo Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Convelo Therapeutics's estimated annual revenue is currently $3.4M per year.
- Convelo Therapeutics's estimated revenue per employee is $155,000
Employee Data
- Convelo Therapeutics has 22 Employees.
- Convelo Therapeutics grew their employee count by 0% last year.
Convelo Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $0.8M | 5 | 0% | N/A | N/A |
#2 | $1.7M | 11 | 0% | N/A | N/A |
#3 | $0.8M | 5 | 0% | N/A | N/A |
#4 | $5.1M | 33 | 14% | N/A | N/A |
#5 | $64.6M | 417 | 2% | N/A | N/A |
#6 | $1.7M | 11 | -8% | N/A | N/A |
#7 | $0.8M | 5 | 0% | N/A | N/A |
#8 | $7.4M | 48 | -41% | N/A | N/A |
#9 | $0.6M | 4 | 0% | N/A | N/A |
#10 | $0.9M | 12 | 20% | N/A | N/A |
What Is Convelo Therapeutics?
Convelo Therapeutics is developing a new class of medicines that unlock the regenerative capacity of the central nervous system. Convelo is pioneering approaches to regenerate the protective myelin coating around nerve cells that is lost in a wide array of neurological diseases including multiple sclerosis, pediatric leukodystrophies, traumatic injury and age-related pathologies such as Alzheimer’s. Convelo has identified key biological targets and a pipeline of drug candidates to provide novel and meaningful solutions for patients and their families.
keywords:N/A
N/A
Total Funding
22
Number of Employees
$3.4M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Cleveland
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $3.9M | 22 | 10% | N/A |
#2 | $5.4M | 22 | 5% | N/A |
#3 | $3.1M | 22 | 5% | N/A |
#4 | $2.2M | 22 | -4% | N/A |
#5 | $5.5M | 22 | -19% | N/A |